Beyond the Surface: Closing Gaps in the Treatment and Management of Hidradenitis Suppurativa and Vitiligo in Patients with Rheumatic Diseases

Registration link: Click here 

Skin comorbidities like hidradenitis suppurativa (HS) and vitiligo are often overlooked but have a profound impact on rheumatic disease patients. These conditions contribute to increased inflammation, disability, and psychological distress – yet they remain underdiagnosed and undertreated.

Join AWIR’s virtual summit to hear dual perspectives from rheumatology and dermatology experts on:

• Inflammatory processes overlapping rheumatic diseases, HS, and vitiligo – as well as their impact on patient outcomes.
• Tips and tools for the timely and appropriate identification, assessment, and monitoring of HS and vitiligo.
• Key data on new and emerging targeted therapies, and personalized approaches for optimal treatment and care

This session is tailored for physicians and advanced practice providers who treat and manage patients with rheumatic conditions and skin comorbidities, and are seeking to improve patient outcomes through evidence-based collaborative care.

Plus, you can earn 1.5 CME/MOC!

Register now to for FREE to reserve your spot, and take the next step in transforming patient care.

How To Participate 

This is a virtual event, so please register following these 3 easy steps:

1. Go to our registration page and register for the Summit.
2. Save your registration email with your link and login information.
3. Log in to the virtual meeting app during the Summit to participate!

The companion virtual meeting app allows you to watch the Summit livestream, review the program agenda and faculty information, send questions, participate in polling questions, complete pre- and post-activity surveys, and find information to claim CME/MOC credits!

Please note: you must register and complete the poll/survey questions in the virtual meeting app to claim your free CME credits.

Location: Virtual with Community Watch Parties*

* Join a Local Watch Party to network with your colleagues and enjoy a memorable meal while watching the presentations. Locations will be added over time; you can register now as a virtual attendee and modify your registration to pick a Watch Party later.

Summit Details

Date: September 13, 2025

Time: 12:00 PM – 15:20 EST

Chairs:

• Grace C. Wright, MD, PhD, FACR
  AWIR President and Founder
• Priya Reddy, MD, FACR
  AWIR Secretary and Treasurer

Speakers

• To be confirmed
  

Program

12:00-12:10 - Welcome Remarks

12:10-12:40  - Accredited Session (1.5 CME/MOC)

14:10-14:25  - Break

14:25-14:40  - Roundtable

14:40-15:10  - Product Theater

15:10-15:20  - Closing Remarks

CME Session Information

Learning Objectives:

• Assess the underlying and overlapping inflammatory pathways in hidradenitis suppurativa (HS), vitiligo, and rheumatic diseases.
• Recognize the impact of HS and vitiligo on disease-specific and patient-reported outcomes in patients with and without rheumatic diseases.
• Evaluate new and emerging treatment options for HS and vitiligo based on mechanisms of action, efficacy and safety data, and patient eligibility.
  
• Apply current evidence, patient factors, and collaborative strategies to make individualized treatment decisions for rheumatology patients with HS and/or vitiligo.

Agenda: 

• Presentation and Impact of HS and Vitiligo on Rheumatology Patients
• Unique and Shared Immunological Pathways of HS and Vitiligo with Rheumatic Diseases
• Validated Tools to Assess Activity, Severity, and Treatment Response of HS and Vitiligo
• New and Emerging Targeted Therapies for Moderate to Severe HS and Vitiligo
• Strategies for Personalized Collaborative Care for Patients with Skin and Joint Disease